We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Industry Insight

Large-Scale Bioproduction of Adherent Cells To Support Advanced Therapy Workflows

In recent years, a number of new cell and gene therapies have been developed to treat a variety of indications, including cancer and inherited retinal dystrophies. While these therapies have proven to be beneficial to patients, their scalability and manufacturability are two enduring challenges. Technology Networks spoke to Tara St.Amand, PhD, MBA, director of business technology, bioprocess at Corning to learn more about the key challenges faced when scaling up the manufacturing of cell products.
Industry Insight

Brooks Automation To Unify Services Under Azenta Life Sciences

Technology Networks spoke to Linda De Jesus, senior vice president and chief commercial officer at Azenta Life Sciences to find out more about the announcement and how this will help drive innovation with greater speed and accuracy.
Industry Insight

Genomic Testing Service To Drive Personalized Medicine for Cancer Patients

The service will enable oncologists, hematologists and other healthcare professionals to undertake rapid and extensive genomic analysis of cancer samples on an unprecedented scale in the UK.
Industry Insight

Humanized Mice: Generation, Advantages and Applications

Technology Networks recently spoke with Dr. Marvin Ouyang, Cyagen’s executive vice president and chief scientific officer, to learn more about humanized mice and the applications they can benefit. In this interview Dr. Ouyang also explains how humanized mice can be generated and highlights some of Cyagen’s capabilities in this area.
Industry Insight

Sustainability Grant Awarded to Honey Bee Research

Technology Networks spoke with Dr. Bertram Brenig and Illumina to find out more about how studying genetic differences in honey bees will improve breeding programs, and how Illumina will support this research.
Industry Insight

Bringing FISH Into the 21st Century

Technology Networks recently spoke with Brian Kirk, BioDot’s vice president of business development, to learn more about FISH, its advantages and applications. In this interview, Brian also highlights how new technology is tackling some of the limitations of classical FISH to bring the technique into the 21st century.
Industry Insight

A No-Code Cloud Platform for Life Science Research

Technology Networks spoke to Guy Levy-Yurista, CEO of Synthace to find out how the new cloud-based solution can support life science research.
Industry Insight

Bypassing Genetic Bottlenecks With the CRISPR-SNP-Chip

Technology Networks spoke to Michael Heltzen, CEO and Dr. Kiana Aran, Chief Scientific Officer of Cardea Bio to find out more about the development of the SNP-Chip and how it has been used in a recent study to detect sickle cell disease and amyotrophic lateral sclerosis (ALS).
Industry Insight

NGS During the COVID-19 Pandemic and Beyond

Technology Networks recently spoke with Dr. Nick Downey, NGS collaborations lead at IDT, to learn more about the ways that NGS is being used as part of the response to the pandemic and gain insights into how and why this varies globally.
Industry Insight

Overcoming the Challenges of Lentiviral Vector Production

In this interview, Dr. Koh Meng Yong discusses the advantages of using lentiviral vectors and some of the applications they are enabling.
Advertisement